A labeled neutral endopeptidase inhibitor as a potential tool for tumor diagnosis and prognosis.
Raguin
Olivier
O
EA 3512, Faculté de Médecine Xavier Bichat, BP416, 16 rue Henri Huchard, 75870 Paris cedex 18, France.
Fournié-Zaluski
Marie-Claude
MC
Romieu
Anthony
A
Pèlegrin
André
A
Chatelet
François
F
Pélaprat
Didier
D
Barbet
Jacques
J
Roques
Bernard P
BP
Gruaz-Guyon
Anne
A
D000818:Animals; D001224:Aspartic Acid / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D001665:Binding Sites; D001667:Binding, Competitive; D045744:Cell Line, Tumor; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D008954:Models, Biological; D015394:Molecular Structure; D009369:Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D015260:Neprilysin / Q000037:antagonists & inhibitors* / Q000737:chemistry*; D010721:Phosphinic Acids / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology; D011379:Prognosis; D011480:Protease Inhibitors / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology
C513788:AR58 compound; C513789:AR60 compound; D010721:Phosphinic Acids; D011480:Protease Inhibitors; D001224:Aspartic Acid; D015260:Neprilysin